Kainic acid-induced neuronal death is attenuated by aminoguanidine but aggravated by L-NAME in mouse hippocampus

Korean Journal of Physiology and Pharmacology

Volumn 13, Issue 4, 2009, Pages 265-271

  Byun, Jong Seon ^a   Lee, Sang Hyun ^a   Jeon, Seong Ho ^a   Kwon, Yong Soo ^a   Hee, Jae Lee ^a   Kim, Sung Soo ^a   Kim, Young Myeong ^a   Kim, Myong Jo ^a   Chun, Wanjoo ^a  

^a Kangwon National University   (South Korea)

Author keywords

Aminoguanidine; iNOS; Kainic acid; L NAME; Neuronal death; Nitric oxide

Indexed keywords

AMINOGUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; KAINIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG EFFICACY; EXCITOTOXICITY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; HIPPOCAMPUS; KNOCKOUT MOUSE; MALE; MICROGLIA; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; SEIZURE;

EID: 70349404449     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2009.13.4.265     Document Type: Article

References (37)

1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615, 2001.
2. Baker H, Farbman AI. Olfactory afferent regulation of the dopamine phenotype in the fetal rat olfactory system. Neuroscience 52: 115-134, 1993.
3. Boer R UMPW, Klein T, Mirau B, Haas S, Baur I. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol 58: 1026-1034, 2000.
4. Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 8: 3-11, 1992.
5. Buisson A, Lakhmeche N, Verrecchia C, Plotkine M, Boulu RG. Nitric oxide: an endogenous anticonvulsant substance. Neuroreport 4: 444-446, 1993a.
6. Buisson A, Margaill I, Callebert J, Plotkine M, Boulu RG. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J Neurochem 61: 690-696, 1993b.
7. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634, 1988.
8. Ciani E, Baldinotti I, Contestabile A. Sustained, long-lasting inhibition of nitric oxide synthase aggravates the neural damage in some models of excitotoxic brain injury. Brain Res Bull 56: 29-35, 2001.
9. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695, 1993.
10. Danielisova V, Nemethova M, Burda J. The protective effect of aminoguanidine on cerebral ischemic damage in the rat brain. Physiol Res 53: 533-540, 2004.
11. Du W, Harvey JA. The nitric oxide synthesis inhibitor L-NAME facilitates associative learning. Prog Neuropsychopharmacol Biol Psychiatry 20: 1183-1195, 1996.
12. Du W, Weiss H, Harvey JA. Associative learning is enhanced by selective neuronal nitric oxide synthase inhibitors and retarded by a nitric oxide donor in the rabbit. Psychopharmacology (Berl) 150: 264-271, 2000.
13. Garthwaite J, Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57: 683-706, 1995.
14. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 57: 737-769, 1995.
15. Haberny KA, Pou S, Eccles CU. Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis. Neurosci Lett 146: 187-190, 1992.
16. Henshall DC, Bonislawski DP, Skradski SL, Araki T, Lan JQ, Schindler CK, Meller R, Simon RP. Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death. Cell Death Differ 8: 1169-1181, 2001.
17. Jones PA, Smith RA, Stone TW. Nitric oxide synthase inhibitors L-NAME and 7-nitroindazole protect rat hippocampus against kainate-induced excitotoxicity. Neurosci Lett 249: 75-78, 1998.
18. Kiedrowski L, Costa E, Wroblewski JT. Glutamate receptor agonists stimulate nitric oxide synthase in primary cultures of cerebellar granule cells. J Neurochem 58: 335-341, 1992.
19. Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 84: 253-256, 1999.
20. Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA 90: 3024-3027, 1993.
21. Laursen SE, Belknap JK. Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16: 355-357, 1986.
22. Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature 399: A7-14, 1999.
23. McNamara JO. Emerging insights into the genesis of epilepsy. Nature 399: A15-22, 1999.
24. Moncada S, Higgs A, Furchgott R. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev 49: 137-142, 1997.
25. Mulsch A, Busse R, Mordvintcev PI, Vanin AF, Nielsen EO, Scheel-Kruger J, Olesen SP. Nitric oxide promotes seizure activity in kainate-treated rats. Neuroreport 5: 2325-2328, 1994.
26. Penix LP, Davis W, Subramaniam S. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents. Epilepsy Res 18: 177-184, 1994.
27. Perez-Asensio FJ, Hurtado O, Burguete MC, Moro MA, Salom JB, Lizasoain I, Torregrosa G, Leza JC, Alborch E, Castillo J, Knowles RG, Lorenzo P. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia. Neurobiol Dis 18: 375-384, 2005.
28. Rondouin G, Bockaert J, Lerner-Natoli M. L-nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. Neuroreport 4: 1187-1190, 1993.
29. Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J Neurosci 15: 8419-8429, 1995.
30. Shapira S, Kadar T, Weissman BA. Dose-dependent effect of nitric oxide synthase inhibition following transient forebrain ischemia in gerbils. Brain Res 668: 80-84, 1994.
31. Southam E, Garthwaite J. The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology 32: 1267-1277, 1993.
32. Starr MS, Starr BS. Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol Biochem Behav 45: 321-325, 1993.
33. Sugimoto K, Iadecola C. Effects of aminoguanidine on cerebral ischemia in mice: comparison between mice with and without inducible nitric oxide synthase gene. Neurosci Lett 331: 25-28, 2002.
34. Takei Y, Takashima S, Ohyu J, Matsuura K, Katoh N, Takami T, Miyajima T, Hoshika A. Different effects between 7-nitroindazole and L-NAME on cerebral hemodynamics and hippocampal lesions during kainic acid-induced seizures in newborn rabbits. Brain Dev 23: 406-413, 2001.
35. Takei Y, Takashima S, Ohyu J, Takami T, Miyajima T, Hoshika A. Effects of nitric oxide synthase inhibition on the cerebral circulation and brain damage during kainic acid-induced seizures in newborn rabbits. Brain Dev 21: 253-259, 1999.
36. Tsuda M, Suzuki T, Misawa M. Aggravation of DMCM-induced seizure by nitric oxide synthase inhibitors in mice. Life Sci 60: 339-343, 1997.
37. Yamamoto S, Golanov EV, Berger SB, Reis DJ. Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J Cereb Blood Flow Metab 12: 717-726, 1992.